- Home
- TRVI vs AWP Comparison
TRVI vs AWP Comparison
Compare TRVI & AWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- AWP
- Stock Information
- Founded
- TRVI 2011
- AWP 2007
- Country
- TRVI United States
- AWP United States
- Employees
- TRVI N/A
- AWP N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- AWP Trusts Except Educational Religious and Charitable
- Sector
- TRVI Health Care
- AWP Finance
- Exchange
- TRVI Nasdaq
- AWP Nasdaq
- Market Cap
- TRVI 341.4M
- AWP 352.4M
- IPO Year
- TRVI 2019
- AWP N/A
- Fundamental
- Price
- TRVI $4.24
- AWP $3.98
- Analyst Decision
- TRVI Strong Buy
- AWP
- Analyst Count
- TRVI 8
- AWP 0
- Target Price
- TRVI $9.31
- AWP N/A
- AVG Volume (30 Days)
- TRVI 454.6K
- AWP 331.5K
- Earning Date
- TRVI 03-19-2025
- AWP 01-01-0001
- Dividend Yield
- TRVI N/A
- AWP 12.48%
- EPS Growth
- TRVI N/A
- AWP N/A
- EPS
- TRVI N/A
- AWP N/A
- Revenue
- TRVI N/A
- AWP N/A
- Revenue This Year
- TRVI N/A
- AWP N/A
- Revenue Next Year
- TRVI N/A
- AWP N/A
- P/E Ratio
- TRVI N/A
- AWP N/A
- Revenue Growth
- TRVI N/A
- AWP N/A
- 52 Week Low
- TRVI $1.39
- AWP $3.06
- 52 Week High
- TRVI $4.68
- AWP $4.20
- Technical
- Relative Strength Index (RSI)
- TRVI 60.00
- AWP 50.46
- Support Level
- TRVI $3.81
- AWP $3.91
- Resistance Level
- TRVI $4.04
- AWP $4.02
- Average True Range (ATR)
- TRVI 0.25
- AWP 0.07
- MACD
- TRVI -0.00
- AWP 0.01
- Stochastic Oscillator
- TRVI 90.89
- AWP 71.21
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About AWP abrdn Global Premier Properties Fund of Beneficial Interest
Aberdeen Global Premier Properties Fund is a diversified, closed-end management investment company. Its objective is to seek high current income and capital appreciation. It predominantly invests in equity and debt securities of domestic and foreign issuers which are principally engaged in the real estate industry, real estate financing or control real estate assets. Its portfolio of investments consists securities of Industrial REITs, Retail REITs, Data Center REITs, Health Care REITs and others.